REGENXBIO Inc. Share Price
NASDAQ: RGNX | Small CapREGENXBIO Inc. Stock Performance
REGENXBIO Inc. Share Price Today
As of 30 October 2026, REGENXBIO Inc.'s share price is $7.43. The stock opened at $7.28, compared to its previous close of $7.28. During today's trading session, REGENXBIO Inc.'s share price traded between $7.28 and $7.63, with an average price of $7.45. Over the past 52 weeks, the stock has recorded a high of $16.19 and a low of $5.46. In terms of performance, REGENXBIO Inc.'s share price has declined by 17.26% over the last six months and is down 41.77% on a year-on-year basis.
REGENXBIO Inc. Share Price Chart
REGENXBIO Inc. Quarterly Profit & Loss
All figures in USD
REGENXBIO Inc. Annual Profit & Loss
All figures in USD
About REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
REGENXBIO Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $7.50 | $7.43 | -1.13% |
Sep 2026 | $9.53 | $7.52 | -19.66% |
Aug 2026 | $9.79 | $9.36 | -3.31% |
Jul 2026 | $12.11 | $9.68 | -19.13% |
Jun 2026 | $6.92 | $11.97 | +70.27% |
May 2026 | $8.97 | $7.03 | -21.71% |
Apr 2026 | $8.78 | $8.98 | +7.29% |
Mar 2026 | $8.70 | $8.37 | -7.46% |
Feb 2026 | $10.95 | $9.04 | -18.84% |
Jan 2026 | $14.23 | $11.14 | -22.74% |
Dec 2025 | $12.53 | $14.43 | +7.81% |
Nov 2025 | $12.35 | $13.38 | +4.86% |